MiNK Therapeutics • INKT
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T-cell therapies to treat cancer and other life-threatening illnesses.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Jennifer S. Buell, PhD$30.5M
Market Cap • 23/04/20242017
(há 7 anos)
2021
(3 years ago)
NASDAQ
Listagem
New York
Sede • New York37
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
INKTSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.